Skip to main content Help with accessibility Skip to main navigation

BEMPEDOIC ACID tablets (Nilemdo®▼) and BEMPEDOIC ACID-EZETIMIBE tablets (Nustendi®▼) for primary hypercholesterolaemia or mixed dyslipidaemia: a multiple prescribing statement

CCG Approval Status:

Date Added: 27 - May - 2021
Body System:
Green

The Pan Mersey Area Prescribing Committee recommends the prescribing of BEMPEDOIC ACID tablets (Nilemdo®▼) and BEMPEDOIC ACID-EZETIMIBE tablets (Nustendi®▼) for primary hypercholesterolaemia or mixed dyslipidaemia in accordance with NICE TA694.